Position in LGND
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$135,701,859
+$50,804,691 QoQ
Shares Held
429,314
+1.0% QoQ
Ownership
2.15%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#14
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 4%
None 4%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. LGND ranks #13 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in LGND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $135,701,859 | 429,314 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $84,897,168 | 425,230 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $81,865,796 | 432,992 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $92,805,947 | 523,913 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $80,090,059 | 704,522 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $78,321,937 | 744,930 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $77,471,483 | 723,019 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $70,765,229 | 707,016 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $59,708,655 | 708,624 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $48,544,320 | 664,081 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $47,229,900 | 661,298 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $36,814,367 | 614,392 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $38,315,524 | 531,422 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $34,567,018 | 469,916 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $30,589,254 | 457,923 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $38,673,528 | 449,118 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $39,498,018 | 442,704 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $42,534,510 | 378,118 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $57,562,280 | 372,668 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $51,934,849 | 372,774 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $53,706,168 | 409,377 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $55,226,061 | 362,257 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $36,377,900 | 365,791 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $36,206,249 | 379,839 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $42,770,084 | 382,388 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $33,604,754 | 462,112 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||